Evidence map›Paper›PMID 17562776›Full record

ArticleInfection and immunity2007

Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells.

Olivia D Schneider, Alison A Weiss, William E Miller

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Structural basis for neutralizing antibody binding to pertussis toxin.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Structural Basis for Antibody Neutralization of Pertussis Toxin.bioRxiv : the preprint server for biology · 2024
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Conquering the host:Frontiers in microbiology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Orexin/hypocretin receptor signalling cascades.British journal of pharmacology · 2014
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Olivia D SchneiderDepartment of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, 2256 Medical Science Building, 231 Albert Sabin Way, Cincinnati, OH 45267-0524, USA.
Alison A Weiss
William E Miller
University of Cincinnati Medical Center · US

Funding

VIRULENCE MUTANTS OF BORDETELLA PERTUSSISR01AI023695 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI MILLER, WILLIAM E, MONACO, JOHN J. · 1986 to 2010
$2.4M
Training in Biologic Threat AgentsT32AI055406 · NIAID · UNIVERSITY OF CINCINNATI · PI WEISS, ALISON A. · 2003 to 2007
$1.5M
NIAID NIH HHS R01 AI 023695NIAID NIH HHS R01 AI023695NIAID NIH HHS T32 AI 055406NIAID NIH HHS T32 AI055406
6 · The paper itself

Abstract

Pertussis toxin (PTx) is an AB(5) toxin produced by the human pathogen Bordetella pertussis. Previous work demonstrates that the five binding (B) subunits of PTx can have profound effects on T lymphocytes independent of the enzymatic activity of the A subunit. Stimulation of T cells with holotoxin (PTx) or the B subunit alone (PTxB) rapidly induces signaling events resulting in inositol phosphate accumulation, Ca(2+) mobilization, interleukin-2 (IL-2) production, and mitogenic cell growth. Although previous reports suggest the presence of PTx signaling receptors expressed on T cells, to date, the receptor(s) and membrane proximal signaling events utilized by PTx remain unknown. Here we genetically and biochemically define the membrane proximal components utilized by PTx to initiate signal transduction in T cells. Using mutants of the Jurkat T-cell line deficient for key components of the T-cell receptor (TCR) pathway, we have compared stimulation with PTx to that of anti-CD3 monoclonal antibody (MAb), which directly interacts with and activates the TCR complex. Our genetic data in combination with biochemical analysis show that PTx (via the B subunit) activates TCR signaling similar to that of anti-CD3 MAb, including activation of key signaling intermediates such as Lck, ZAP-70, and phospholipase C-gamma1. Moreover, the data indicate that costimulatory activity, as provided by CD28 ligation, is required for PTx to fully stimulate downstream indicators of T-cell activation such as IL-2 gene expression. By illuminating the signaling pathways that PTx activates in T cells, we provide a mechanistic understanding for how these signals deregulate immune system functions during B. pertussis infection.

Indexed as

Signal TransductionAntibodies, MonoclonalBordetella pertussisCalciumCD28 AntigensCD3 ComplexCell LineCell ProliferationHumansInositol PhosphatesInterleukin-2IsoenzymesJurkat CellsLymphocyte Specific Protein Tyrosine Kinase p56(lck)Models, BiologicalPertussis ToxinAntibodies, MonoclonalCalciumCD28 AntigensCD3 ComplexInositol PhosphatesInterleukin-2IsoenzymesLymphocyte Specific Protein Tyrosine Kinase p56(lck)Pertussis ToxinPhospholipase C betaPhospholipase C gammaReceptors, Antigen, T-CellType C PhospholipasesZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID17562776
PMCPMC1951969
OpenAlexW2129763878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.